$145.88
2.621.83%
At close: -
$145.88
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Latest news for Neurocrine Biosciences (NASDAQ:NBIX) Stock
Neurocrine Biosciences Stock (NASDAQ: NBIX)
Categories: All
Tuesday, January 21, 2025
Wednesday, January 08, 2025
Monday, December 23, 2024
Sunday, December 22, 2024
Friday, December 20, 2024
Monday, December 16, 2024
- Neurocrine Biosciences shares are trading hig...
- Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
- Wedbush Reiterates Outperform on Neurocrine B...
- HC Wainwright & Co. Reiterates Buy on Neurocr...
- Reported Friday, Neurocrine Biosciences' CREN...
Tuesday, December 03, 2024
Wednesday, November 13, 2024
Tuesday, November 12, 2024
Monday, November 11, 2024
Thursday, November 07, 2024
Monday, November 04, 2024
Friday, November 01, 2024
Thursday, October 31, 2024
Wednesday, October 30, 2024
Tuesday, October 29, 2024
Thursday, October 17, 2024
Thursday, October 10, 2024
Tuesday, October 08, 2024
Friday, October 04, 2024
Monday, September 30, 2024
Monday, September 16, 2024
Friday, September 13, 2024
Thursday, September 12, 2024
Monday, September 09, 2024
Sunday, September 08, 2024
Monday, September 02, 2024
Thursday, August 29, 2024
- Neurocrine Biosciences shares are trading hig...
- Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock
- Cantor Fitzgerald Maintains Overweight on Neu...
- RBC Capital Maintains Sector Perform on Neuro...
- NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday
- HC Wainwright & Co. Reiterates Buy on Neurocr...
- Needham Reiterates Hold on Neurocrine Bioscie...
- Piper Sandler Upgrades Neurocrine Biosciences...
- BMO Capital Maintains Market Perform on Neuro...